Kiora Pharmaceuticals Inc. (KPRX:NASDAQ) rocketted at $8.16, a gain of 32.5%. On Tue, Oct 18, 2022, KPRX:NASDAQ touched a New 2-Week Intraday High of $10.39. The stock appeared on our News Catalysts scanner on Mon, Oct 17, 2022 at 12:06 PM in the 'BIOTECH' category. From Wed, Oct 05, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Tue, Oct 18, 2022 at $10.39 with a volume of 14M+.
About Kiora Pharmaceuticals Inc. (KPRX:NASDAQ)
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- Akouos Inc. (AKUS:NASDAQ), 88.16%
- Rubicon Technologies Inc. Class A (RBT:NYSE), 58.18%
- Helbiz Inc. (HLBZ:NASDAQ), 58.07%
- Quoin Pharmaceuticals Ltd. (QNRX:NASDAQ), 44.44%
- AVEO Pharmaceuticals, Inc. (AVEO:NASDAQ), 42.37%
- Zovio Inc (ZVO:NASDAQ), 38.7%
- Digital Brands Group Inc. (DBGI:NASDAQ), 35.31%
- EQONEX LIMITED (EQOS:NASDAQ), 35.07%
- Creatd Inc. (CRTD:NASDAQ), 33.17%
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 32.47%